Clinical Research
- Glybera Is First Gene Therapy Approved By European Commission
-
Glybera is the first gene therapy approved by regulatory authorities in the Western world. niQure announced it has received approval from the European Commission for the gene therapy Glybera(R) (alipogene tiparvovec), a treatment for patients with lipopro ...
Article - News Staff - Nov 3 2012 - 10:38am
- Stem Cell Therapy No Benefit In Heart Attack Recovery
-
Autologous stem cells from bone marrow 3 or 7 days following a heart attack did not improve heart function six months later, according to a new clinical trial. The results of this TIME (Transplantation In Myocardial Infarction Evaluation) trial were prese ...
Article - News Staff - Nov 6 2012 - 10:25pm
- Phase III Clinical Trial Of Regenerative Medicine For Heart Failure
-
Cardio3 BioSciences (C3BS) announced it has received authorization from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C3 ...
Article - News Staff - Nov 22 2012 - 10:00am
- Clinical Trial Of Intravenous Erwinaze For Acute Lymphoblastic Leukemia
-
...
Article - News Staff - Dec 4 2012 - 1:30pm
- How To Identify The Birth Of New Cardiac Cells
-
New cells develop in the heart but how these cardiac cells are born and how frequently they are generated remains unclear. New research from Brigham and Women's Hospital used a novel method to identify these new heart cells and describe their origins ...
Article - News Staff - Dec 10 2012 - 4:32am
- Are Clinical Trials Biased By Industry Sponsorship?
-
Clinical trials are obviously important. The results influence what drugs are approved by regulatory bodies, which can have a billion-dollar impact on companies. Clinical trials have always been sponsored by industry- there has never been a meaningful g ...
Article - News Staff - Dec 12 2012 - 5:30am
- RS13702- Gene Variant Regulates Triglyceride Levels, Carriers Less Likely To Develop Heart Disease
-
Scientists have discovered a new gene mechanism that appears to regulate triglyceride levels and may protect carriers of a gene variant against cardiovascular disease, especially among those with greater intakes of polyunsaturated fat (PUFA). ...
Article - News Staff - Dec 15 2012 - 5:26pm
- Insulin Plus Betacellulin Inhibitor Limits Diabetes-Related Vision Damage In Mice
-
By combining insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin, Cleveland Clinic researcher Bela Anand-Apte, MD, PhD was able to halt the progression of diabetic macular edema (DME), according to data preseneted at the American S ...
Article - News Staff - Dec 24 2012 - 11:33am
- BOVIGAM IFN-Gamma Tuberculosis Test Gets Positive Assessment In Europe
-
The European Food Safety Authority (EFSA) has reviewed field performance data of the BOVIGAM(R)Interferon-gamma (IFN-gamma) test and recommended such tests for inclusion in the official list of stand-alone tests for bovine tuberculosis (TB). BOVIGAM is cu ...
Article - News Staff - Dec 27 2012 - 12:00pm
- Type 1 Diabetes Cured In Dogs
-
Researchers from the Universitat Autònoma de Barcelona report they can cure diabetes in large animals with a single session of gene therapy. Writing in Diabetes, they said the dogs recovered their health and no longer show symptoms of the disease. In some ...
Article - News Staff - Feb 9 2013 - 1:35pm
Know Science And Want To Write?
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
